Company intelligence / Profile preview

NuraLogix

Toronto, Ontario, Canadanuralogix.ai ↗

Ownership: Private
Employees: ~65
Development stage: Commercial

Overview

NuraLogix has developed a commercialized, AI-powered platform that uses video imaging to extract facial blood flow data and provide over 100 health and wellness parameters—including blood pressure, heart rate variability, mental stress index, BMI estimation, skin age analysis, and risk scores for conditions such as heart attack or stroke. These results are intended for general wellness awareness rather than clinical diagnosis or treatment.

Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

LaFiya TeleHealth (Nigeria)

Beyond the preview

Go deeper on NuraLogix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NuraLogix.

Explore the full profile